CopyMark Law Group
4.9/5
Drawing for OSTEOBIOTIC

USPTO serial 79345466

OSTEOBIOTIC

Reviewed by CopyMark Law Group

Reg. 7095575Status 700Registered
Filing date
Status date
Registration date
Jul 4, 2023
Examiner
LIEBL, ALEXANDRA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with OSTEOBIOTIC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey P. Thennisch

Jeffrey P. Thennisch Thennisch Law Group, PC7111 Dixie Highway #210Clarkston, MI 48346UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals preparations for the treatment of bone and cartilage tissue; medicinal preparations for the treatment of bone and cartilage tissue; dietary supplements for human beings and animals; amino acids for medical purposes; dietary and nutritional supplements; mineral dietary supplements; dietary supplements; royal jelly dietary supplements; pollen dietary supplements; Pharmaceutical drugs for medical purposes for the treatment of bone and cartilage tissue; medicines for human purposes, namely, tablets, powder, capsules for the treatment of bone and cartilage tissue; biological preparations for medical purposes for the treatment of bone and cartilage tissue; pharmaceutical preparations for the prevention of osteoarthritis, osteoporosis, periodontitis, periodontal disease and for acceleration of fracture fusion; chemico-pharmaceutical preparations for the prevention of osteoarthritis, osteoporosis, periodontitis, periodontal disease and for acceleration of fracture fusion; chemical preparations for pharmaceutical purposes, namely, for osteoarthritis, osteoporosis, periodontitis, periodontal disease and for acceleration of fracture fusion; Dietetic infusions for medical use; herbal tinctures for medical purposes; decoctions of medicinal herb for pharmaceutical purposes; drone brood based dietary supplementsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 13, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 10, 2023XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Oct 10, 2023XXCRGENERIC MADRID TRANSACTION CREATED—
Oct 4, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 4, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 4, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 18, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 18, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 29, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 13, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 13, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 11, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 11, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 9, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 9, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 9, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 9, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 9, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 7, 2023RFNTREFUSAL PROCESSED BY IB—
Jan 18, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 18, 2023RFRRREFUSAL PROCESSED BY MPU—
Nov 9, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 8, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 4, 2022DOCKASSIGNED TO EXAMINER—
Jul 26, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 22, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 21, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance